1-propyl-4-O-beta galactopyranosyl-alpha galactopyranoside

structure given in first source

Also Known As:

PBGAG; alpha-D-Galactopyranoside, propyl 4-O-beta-D-galactopyranosyl-, (3beta)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Malaria 11/23/2010 - "Our goal was to determine the feasibility of developing transgenic Plasmodium berghei that expresses HIV-1 Gag, PbGAG, as a conceptual bivalent vaccine against both HIV-1 infection and malaria. "
2.	Infections 11/23/2010 - "Our goal was to determine the feasibility of developing transgenic Plasmodium berghei that expresses HIV-1 Gag, PbGAG, as a conceptual bivalent vaccine against both HIV-1 infection and malaria. "

1.	Combined Vaccines